换一批The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.
第一作者：
Leila,Talby
第一单位：
Centre d'Immunologie de Marseille-Luminy (CIML), CNRS-INSERM-Univ. Méditerranée, Campus de Luminy, Case 906, 13288 Marseille Cedex 09, France.
作者：
医学主题词
蒽环类(Anthracyclines);抗原, CD34(Antigens, CD34);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);天冬酰胺酶(Asparaginase);原始细胞危象(Blast Crisis);伯基特淋巴瘤(Burkitt Lymphoma);儿童(Child);儿童, 学龄前(Child, Preschool);可的松(Cortisone);DNA结合蛋白质类(DNA-Binding Proteins);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);基因表达谱(Gene Expression Profiling);基因表达调控, 白血病(Gene Expression Regulation, Leukemic);人类(Humans);婴儿(Infant);男(雄)性(Male);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);试验预期值(Predictive Value of Tests);原癌基因蛋白质c-bcr(Proto-Oncogene Proteins c-bcr);转录因子(Transcription Factors);长春新碱(Vincristine)
DOI
10.1016/j.leukres.2005.10.007
PMID
16297978
发布时间
2015-11-19
- 浏览8
Leukemia research
665-76页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
